| Literature DB >> 30213868 |
Jinliang Yang1,2, Cheng-Ting Eddy Yeh1, Raghuprakash Kastoori Ramamurthy2, Xinshuai Qi3, Rohan L Fernando4, Jack C M Dekkers4, Dorian J Garrick4, Dan Nettleton5, Patrick S Schnable6.
Abstract
Advances in next generation sequencing technologies and statistical approaches enable genome-wide dissection of phenotypic traits via genome-wide association studies (GWAS). Although multiple statistical approaches for conducting GWAS are available, the power and cross-validation rates of many approaches have been mostly tested using simulated data. Empirical comparisons of single variant (SV) and multi-variant (MV) GWAS approaches have not been conducted to test if a single approach or a combination of SV and MV is effective, through identification and cross-validation of trait-associated loci. In this study, kernel row number (KRN) data were collected from a set of 6,230 entries derived from the Nested Association Mapping (NAM) population and related populations. Three different types of GWAS analyses were performed: 1) single-variant (SV), 2) stepwise regression (STR) and 3) a Bayesian-based multi-variant (BMV) model. Using SV, STR, and BMV models, 257, 300, and 442 KRN-associated variants (KAVs) were identified in the initial GWAS analyses. Of these, 231 KAVs were subjected to genetic validation using three unrelated populations that were not included in the initial GWAS. Genetic validation results suggest that the three GWAS approaches are complementary. Interestingly, KAVs in low recombination regions were more likely to exhibit associations in independent populations than KAVs in recombinationally active regions, probably as a consequence of linkage disequilibrium. The KAVs identified in this study have the potential to enhance our understanding of the genetic basis of ear development.Entities:
Keywords: GWAS KRN maize Bayesian; MPP; Multiparent Advanced Generation Inter-Cross (MAGIC); multiparental populations
Mesh:
Year: 2018 PMID: 30213868 PMCID: PMC6222574 DOI: 10.1534/g3.118.200636
Source DB: PubMed Journal: G3 (Bethesda) ISSN: 2160-1836 Impact factor: 3.154
Figure 1Phenotypic distributions of the KRN trait in GWAS and validation populations. (A) Density plots of the four GWAS populations. Embedded picture shows the typical KRN counts for B73, B73xMo17 (BxM), Mo17xB73 (MxB) and Mo17 lines. (B) Density plots of two validation populations, elite inbred lines and extreme KRN accessions. Embedded pictures shows examples of an extreme low KRN accession and an extreme high KRN accession. (C) Density plots of cycle 30 long ear (C30 LE) and cycle 30 short ear (C30 SE) in the BSLE population. Embedded pictures indicate the ear length and KRN variation after 30 generations of selection. Blue and red dashed lines indicate the mean KRN values of B73 (KRN = 17.1) and Mo17 (KRN = 10.8).
Figure 2Stacked plots of GWAS and QTL results. From upper to lower panels are results from the Bayesian-based multi-variant (A) stepwise regression (B) and single variant(C) models for GWAS and the joint QTL mapping result (D). The red dashed line in the QTL plot indicates the 1,000 permutation threshold and black lines show the QTL confidence intervals. Red squares in panel (A), triangles in panel (B) and circles in panel (C) indicate the kernel row number associated variants selected for further genetic validation.
Figure 3Genetic validation results of selected kernel row number associated variants (KAVs). (A) Transformed P values using single variant (SV) model and posterior model frequencies using Bayesian-based multi-variant (BMV) model were extracted and plotted for the 77 informative KAVs identified by at least one of the three GWAS models. KAVs detected only by the SV model are plotted in the lower right quadrant, KAVs detected only by the stepwise regression model are plotted as non-gray dots in the lower left quadrant, the KAVs detected only by the BMV model are plotted in the upper left quadrant, KAVs detected by both the SV and BMV models are plotted in the upper right quadrant and control variants are plotted as gray dots in the lower left quadrant. Validated KAVs are marked in red. A control variant is a genomic variant that is randomly chosen from a set of SNPs that were not associated with KRN in the initial GWAS. (B) Venn diagram of the validation results.